Synthesis of tetracyclines and analogues thereof
US-2016340325-A1 · Nov 24, 2016 · US
US9688644B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9688644-B2 |
| Application number | US-201514792493-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 6, 2015 |
| Priority date | Apr 30, 2009 |
| Publication date | Jun 27, 2017 |
| Grant date | Jun 27, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides more efficient routes for preparing the enone intermediate and allows for substituents at positions 4a, 5, 5a, and 12a of the tetracycline ring system.
Opening claim text (preview).
What is claimed is: 1. A compound of formula (VII): or a salt thereof; wherein: R 3 and R 4 are each independently hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR B ; —CH 2 OR B ; —CH 2 R B ; —CH 2 N(R B ) 2 ; —C(═O)R B ; —CO 2 R B ; —CN; —SCN; —SR B ; —SOR B ; —SO 2 R B ; —N 3 ; —NO 2 ; —N(R B ) 2 ; —NHC(O)R B ; —NHSO 2 R B ; or —C(R B ) 3 ; wherein each occurrence of R B is independently hydrogen, halogen, azido, a protecting group, aliphatic, heteroaliphatic, haloaliphatic, acyl, aryl, heteroaryl, alkoxy, aryloxy, alkylthio, arylthio, amino, alkylamino, dialkylamino, heteroaryloxy, or heteroarylthio; or R 3 and R 4 are taken together to form ═O or ═C(R B ) 2 ; R 5 , R 9 , R 10 , and R 11 are each independently hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR C ; —CH 2 OR C ; —CH 2 R C ; —CH 2 N(R C ) 2 ; —C(═O)R C ; —CO 2 R C ; —CN; —SCN; —SR C ; —SOR C ; —SO 2 R C ; —N 3 ; —NO 2 ; —N(R C ) 2 ; —NHC(O)R C ; —NHSO 2 R C ; or —C(R C ) 3 ; wherein each occurrence of R C is independently hydrogen, halogen, azido, a protecting group, aliphatic, heteroaliphatic, haloaliphatic, acyl, aryl, heteroaryl, alkoxy, aryloxy, alkylthio, arylthio, amino, alkylamino, dialkylamino, heteroaryloxy, or heteroarylthio; or R 5 is ═C(R C ) 2 ; and R P is hydrogen, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, haloaliphatic, a protecting group, substituted or unsubstituted acyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; provided that when R 9 is —OR C , then R 10 and R 11 are not simultaneously hydrogen. 2. The compound of claim 1 , wherein R 3 is hydrogen, halogen, —OR B , or C 1-6 alkyl. 3. The compound of claim 1 , wherein R 4 is hydrogen, halogen, —OR B , or C 1-6 alkyl. 4. The compound of claim 1 , wherein R 5 is —N(R C ) 2 or —OR C . 5. The compound of claim 1 , wherein R 9 is —OR C . 6. The compound of claim 1 , wherein R 9 is C 1-6 alkyl. 7. The compound of claim 1 , wherein R 9 is —N(R C ) 2 . 8. The compound of claim 1 , wherein R 10 is substituted or unsubstituted alkyl, —OR C , or halogen. 9. The compound of claim 1 , wherein R 11 is hydrogen or substituted or unsubstituted alkyl. 10. The compound of claim 1 , wherein R 11 is —OR C or —N(R C ) 2 . 11. The compound of claim 1 of formula: or a salt thereof. 12. The compound of claim 1 of formula: or a salt thereof. 13. The compound of claim 1 of formula: or a salt thereof. 14. The compound of claim 1 , wherein R 10 is halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR C ; —CH 2 OR C ; —CH 2 R C ; —CH 2 N(R C ) 2 ; —C(═O)R C ; —CO 2 R C ; —CN; —SCN; —SR C ; —SOR C ; —SO 2 R C ; —N 3 ; —NO 2 ; —N(R C ) 2 ; —NHC(O)R C ; —NHSO 2 R C ; or —C(R C ) 3 . 15. A method of preparing an enone of formula (VII): or a salt thereof; wherein: R 3 and R 4 are each independently hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR B ; —CH 2 OR B ; —CH 2 R B ; —CH 2 N(R B ) 2 ; —C(═O)R B ; —CO 2 R B ; —CN; —SCN; —SR B ; —SOR B ; —SO 2 R B ; —N 3 ; —NO 2 ; —N(R B ) 2 ; —NHC(O)R B ; —NHSO 2 R B ; or —C(R B ) 3 ; wherein each occurrence of R B is independently hydrogen, halogen, azido, a protecting group, aliphatic, heteroaliphatic, haloaliphatic, acyl, aryl, heteroaryl, alkoxy, aryloxy, alkylthio, arylthio, amino, alkylamino, dialkylamino, heteroaryloxy, or heteroarylthio; or R 3 and R 4 are taken together to form ═O or ═C(R B ) 2 ; R 5 , R 9 , and R 11 are each independently hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR C ; —CH 2 OR C ; —CH 2 R C ; —CH 2 N(R C ) 2 ; —C(═O)R C ; —CO 2 R C ; —CN; —SCN; —SR C ; —SOR C ; —SO 2 R C ; —N 3 ; —NO 2 ; —N(R C ) 2 ; —NHC(O)R C ; —NHSO 2 R C ; or —C(R C ) 3 ; R 10 is hydrogencyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl; each occurrence of R C is independently hydrogen, halogen, azido, a protecting group, aliphatic, heteroaliphatic, haloaliphatic, acyl, aryl, heteroaryl, alkoxy, aryloxy, alkylthio, arylthio, amino, alkylamino, dialkylamino, heteroaryloxy, or heteroarylthio; each R P is independently hydrogen, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, haloaliphatic, a protecting group, substituted or unsubstituted acyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; the method comprising steps of: (a) deprotonating an isoxazole of formula (I): or a salt thereof; with a base and reacting the deprotonated isoxazole with an enone of formula (II): or a salt thereof, wherein: each occurrence of R Q is independently hydrogen, C 1-6 alkyl, —Si(OR Z ) 3 , or —Si(R Z ) 3 , and each occurrence of R Z is independently hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; or a substituted or unsubstituted heteroaryl; to yield a compound of formula (III): or a salt thereof; wherein M is a counterion generated by the base; (b) treating the compound of formula (III) with a base
the ring being saturated · CPC title
condensed with carbocyclic rings or ring systems · CPC title
containing five-membered rings · CPC title
Antibacterial agents · CPC title
to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.